Search Results - Naval Daver

Refine Results
  1. 1
    FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm

    FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm by Naval Daver, Sangeetha Venugopal, Farhad Ravandi

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Targeting Immune Checkpoints in Hematologic Malignancies

    Targeting Immune Checkpoints in Hematologic Malignancies by Gheath Alatrash, Naval Daver, Elizabeth A. Mittendorf

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    How I Treat patients with AML using azacitidine and venetoclax

    How I Treat patients with AML using azacitidine and venetoclax by Andrew H. Wei, Sun Loo, Naval Daver

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments

    T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments by Naval Daver, Ahmad S. Alotaibi, Veit Bücklein, Marion Subklewe

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia by Nicholas J. Short, Hagop M. Kantarjian, Farhad Ravandi, Naval Daver

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Targeting FLT3 mutations in AML: review of current knowledge and evidence

    Targeting FLT3 mutations in AML: review of current knowledge and evidence by Naval Daver, Richard F. Schlenk, Nigel H. Russell, Mark J. Levis

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia

    The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia by Hun Ju Lee, Naval Daver, Hagop M. Kantarjian, Srđan Verstovšek, Farhad Ravandi

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions

    Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions by Bachar Samra, Marina Konopleva, Alessandro Isidori, Naval Daver, Courtney D. DiNardo

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia

    Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia by Bruno C. Medeiros, Steven M. Chan, Naval Daver, Brian A. Jonas, Daniel A. Pollyea

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    The emerging role of immune checkpoint based approaches in AML and MDS

    The emerging role of immune checkpoint based approaches in AML and MDS by Prajwal Boddu, Hagop M. Kantarjian, Guillermo Garcia‐Manero, James P. Allison, Padmanee Sharma, Naval Daver

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in <i>FLT3</i>-mutated acute myeloid leukemias: from concept to clinical trial

    Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in <i>FLT3</i>-mutated acute myeloid leukemias:... by Weiguo Zhang, Charlie Ly, Jo Ishizawa, Hong Mu, Vivian Ruvolo, Sharon Shacham, Naval Daver, Michael Andreeff

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    New directions for emerging therapies in acute myeloid leukemia: the next chapter

    New directions for emerging therapies in acute myeloid leukemia: the next chapter by Naval Daver, Andrew H. Wei, Daniel A. Pollyea, Amir T. Fathi, Paresh Vyas, Courtney D. DiNardo

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Resistance to targeted therapies: delving into FLT3 and IDH

    Resistance to targeted therapies: delving into FLT3 and IDH by Sai Prasad Desikan, Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Marina Konopleva, Farhad Ravandi

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes

    Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes by Naval Daver, Prajwal Boddu, Guillermo Garcia‐Manero, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Hagop M. Kantarjian

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Secondary mutations as mediators of resistance to targeted therapy in leukemia

    Secondary mutations as mediators of resistance to targeted therapy in leukemia by Naval Daver, Jorge E. Cortés, Farhad Ravandi, Keyur P. Patel, Jan A. Burger, Marina Konopleva, Hagop M. Kantarjian

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges

    Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges by Nicholas J. Short, Marina Konopleva, Tapan M. Kadia, Gautam Borthakur, Farhad Ravandi, Courtney D. DiNardo, Naval Daver

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis

    Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis by Sebastian Wurster, Nathaniel D. Albert, Uddalak Bharadwaj, Moses M. Kasembeli, Jeffrey J. Tarrand, Naval Daver, Dimitrios P. Kontoyiannis

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Myelopathy following intrathecal chemotherapy in adults: a single institution experience

    Myelopathy following intrathecal chemotherapy in adults: a single institution experience by David Cachia, Carlos Kamiya-Matsuoka, Chelsea C. Pinnix, Linda Chi, Hagop M. Kantarjian, Jorge E. Cortés, Naval Daver, Karin Woodman

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis by Lucia Masárová, Ahmad Alhuraiji, Prithviraj Bose, Naval Daver, Naveen Pemmaraju, Jorge E. Cortés, Sherry Pierce, Hagop M. Kantarjian, Srđan Verstovšek

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis

    Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis by Lucia Masárová, Prithviraj Bose, Naval Daver, Naveen Pemmaraju, Kate J. Newberry, Taghi Manshouri, Jorge E. Cortés, Hagop M. Kantarjian, Srđan Verstovšek

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: